Kent Holtorf, M.D., is a renowned innovator in modern medicine and Medical Director of the Holtorf Medical Group. Previously leading 23 affiliate centers and 12 franchises, he has advanced the integration of peptide and bioregulator therapies, transforming the treatment of complex health conditions. Founder of the nonprofit National Academy of Hypothyroidism (NAHypothyroidism.org) and Integrative Peptides, Dr. Holtorf has authored numerous groundbreaking published papers challenging outdated thyroid treatment practices.
His expertise includes chronic fatigue syndrome, fibromyalgia, long-COVID, tick-borne illnesses, neurodegenerative diseases, immune modulation, T3 optimization, mitochondrial dysfunction, senolytic therapies, and longevity. His groundbreaking work has provided hope for those suffering from conditions once deemed untreatable, exemplified by his personal recovery from heart failure and chronic Lyme disease.
Dr. Holtorf is an internationally recognized educator and lecturer, with nearly 100 CME-approved presentations and significant contributions to medical education and research. He has authored Mold Illness: The Peptide Protocol for the Rapid Treatment of CIRS, along with numerous influential medical publications.
Dr. Holtorf’s contributions extend beyond medicine into public discourse. He has appeared on CNBC, ABC News, CNN, Fox News, Good Morning America, The Today Show, Forbes, The Wall Street Journal, Los Angeles Times, US News and World Report, and more. His commentary has illuminated new paths in understanding complex diseases, challenged traditional medical paradigms, and introduced innovative perspectives in endocrinology, longevity, and infectious diseases.
